STAY UP TO DATE
Latest News
All Latest News
Showing -9-0 of 30 articles
-
Adare And Laxxon Announce 3D-Printing Collaboration
Press Release ArchivesPHILADELPHIA, PA, September 18, 2024 — Adare Pharma Solutions, a global technology-driven CDMO focused on oral dosage forms, today announced a collaboration with Laxxon Medical, a pharma-technology company pioneering a new generation of advanced phar... LEARN MORE -
Shapiro Administration Invests Nearly $3 Million to Bring Adare Pharma Solutions’ Headquarters to Pennsylvania, Creating 115 New, Well-Paying Jobs in Philadelphia
Press Release ArchivesThe life sciences company is investing at least $16.8 million to relocate its headquarters to PA from New Jersey and upgrade its two current Philadelphia facilities, building on Pennsylvania’s reputation as a life sciences leader. FROM THE OFFICE OF ... LEARN MORE -
Adare Expands Global High Potency Handling & Packaging Capabilities
Press Release ArchivesLAWRENCEVILLE, N.J., May 1, 2024 — Adare Pharma Solutions, a global technology-driven CDMO specializing in oral dosage forms, today announced expansions of its high potency handling capabilities in the United States and Europe. In the United States, ... LEARN MORE -
Adare Pharma Solutions Expanding Oral Dose Capabilities In Europe
Press Release ArchivesLAWRENCEVILLE, NJ, March 12, 2024 — Adare Pharma Solutions, a global technology-driven CDMO focused on oral dosage forms, today announced it is further investing in its Pessano facility in Milan, Italy, with the addition of a high-shear mixer granula... LEARN MORE -
Adare Pharma Solutions To Expand Packaging & Warehousing Capabilities In Europe
Press Release ArchivesLAWRENCEVILLE, NJ, March 5, 2024 — Adare Pharma Solutions, a global technology-driven CDMO focused on oral dosage forms, today announced that work has begun to add packaging capabilities and further warehousing capacity at its Pessano facility in Mil... LEARN MORE -
Adare Pharma Solutions announces divestiture of postbiotics pioneer Adare Biome to dsm-firmenich
Press Release ArchivesPHILADELPHIA, Pennsylvania, July 3, 2023 — Adare Pharma Solutions, a global technology-driven CDMO focused on oral dosage forms, today announced the completion of its divestiture of its Adare Biome business unit, a pioneer in the development and manu... LEARN MORE -
DSM agrees to terms to acquire postbiotics pioneer Adare Biome
Press Release ArchivesHEERLEN, Netherlands — April 19, 2023 Royal DSM, a global science-based leader in health, nutrition and bioscience, announces that it has entered into exclusive negotiations with Adare Pharma Solutions in order to acquire Adare Biome, a pioneer in th... LEARN MORE -
Adare Pharma Solutions Selects Vantage to Lead Major Packaging Facility Upgrade
Press Release ArchivesHILLSBOROUGH, NJ — March 21, 2023 Adare Pharma Solutions, a leading contract development and manufacturing organization, today announced it has selected Vantage Solutions to lead a major upgrade of their pharmaceutical packaging capabilities. Vantage... LEARN MORE -
Global CDMO Adare Pharma Solutions Harmonizing Quality with Veeva Vault Quality Suite
Press Release ArchivesVault Quality Suite to connect quality processes, documents, and training on a single platform for improved efficiency and collaboration PLEASANTON, CA — Jan. 11, 2023 Veeva Systems (NYSE: VEEV) today announced that Adare Pharma Solutions, a contract... LEARN MORE -
Adare Pharma Solutions Announces Appointment of Tom Sellig as Chief Executive Officer
Press Release ArchivesSellig Will Drive Enhanced Customer Service and Go-To-Market Strategy LAWRENCEVILLE, New Jersey, January 6, 2022 – Adare Pharma Solutions (“Adare”), a global, technology-driven contract development and manufacturing organization (CDMO), today announc... LEARN MORE
